Back to Search
JOAN KANDEL, DO
DO
Family Medicine Physician
NPI: 1235172842Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
A-2282-19(NM)3986(AZ)
Research & Publications (20)
Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma.
PMID 19148474·Int J Oncol·2009
7-preclinical
Neonatal hepatic mesenchymal hamartoma causing cardiac failure and disseminated intravascular coagulopathy.
PMID 19370509·Am J Perinatol·2009
5-case
Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade.
PMID 19082480·Int J Oncol·2009
7-preclinical
A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis.
PMID 18559519·Cancer Res·2008
7-preclinical
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.
PMID 18234958·Mol Cancer Res·2008
7-preclinical
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study.
PMID 18202416·J Clin Oncol·2008
3-trial
Ovarian repositioning in pediatric cancer patients: Flexible techniques accommodate pelvic radiation fields.
PMID 16261563·Pediatr Blood Cancer·2007
5-case
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
PMID 16618763·Cancer Res·2006
7-preclinical
Crystal structure of pseudouridine synthase RluA: indirect sequence readout through protein-induced RNA structure.
PMID 17188032·Mol Cell·2006
8-other
Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature.
PMID 16880251·Pediatrics·2006
5-case
Preoperative angiography with embolization and radiofrequency ablation as novel adjuncts to safe surgical resection of a large, vascular sacrococcygeal teratoma.
PMID 16479404·Pediatr Surg Int·2006
5-case
Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
PMID 16179496·Mol Cancer Res·2005
4-observational
Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.
PMID 15289855·Int J Oncol·2004
7-preclinical
TNP-470 promotes initial vascular sprouting in xenograft tumors.
PMID 15026554·Mol Cancer Ther·2004
7-preclinical
Antiangiogenic therapy for the treatment of pediatric solid malignancies.
PMID 14765371·Semin Pediatr Surg·2004
6-review
Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.
PMID 14757844·Mol Cancer Res·2004
7-preclinical
Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.
PMID 14614702·J Pediatr Surg·2003
4-observational
Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.
PMID 14612937·Int J Oncol·2003
7-preclinical
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.
PMID 12805568·Proc Natl Acad Sci U S A·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 90 MEDICINE WAY
DULCE, NM 87528 - Phone
- (505) 360-5995
Quick Facts
- NPI
- 1235172842
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile